Advertisement
Editorial| Volume 13, ISSUE 3, P367-373, May 2019

Low LDL cholesterol—Friend or foe?

      Highlights

      • The inaccuracy of calculated low-density lipoprotein cholesterol is well known.
      • Evidence that low levels of low-density lipoprotein cholesterol directly result in adverse events is lacking.
      • Individuals with heterozygous apolipoprotein B–related familial hypobetalipoproteinemia are at risk of fatty liver disease.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Lipidology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Vos M.B.
        • Abrams S.H.
        • Barlow S.E.
        • et al.
        NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert committee on NAFLD (ECON) and the North American society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN).
        J Pediatr Gastroenterol Nutr. 2017; 64: 319-334
        • Sonmez A.
        • Nikolic D.
        • Dogru T.
        • et al.
        Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
        J Clin Lipidol. 2015; 9: 576-582
        • Expert Panel on Integrated Guidelines for Cardiovascular H, Risk Reduction in C, Adolescents
        • National Heart, Lung, and Blood Institute
        Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report.
        Pediatrics. 2011; 128: S213-S256
        • Hickman T.B.
        • Briefel R.R.
        • Carroll M.D.
        • et al.
        Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the third national health and nutrition examination survey.
        Prev Med. 1998; 27: 879-890
        • Cohen J.
        • Pertsemlidis A.
        • Kotowski I.K.
        • Graham R.
        • Garcia C.K.
        • Hobbs H.H.
        Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9.
        Nat Genet. 2005; 37: 161-165
        • Berge K.E.
        • Ose L.
        • Leren T.P.
        Missense mutations in the PCSK9 gene are associated with hypocholesterolemia and possibly increased response to statin therapy.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1094-1100
        • Tarugi P.
        • Averna M.
        • Di Leo E.
        • et al.
        Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
        Atherosclerosis. 2007; 195: e19-e27
        • Burnett J.R.
        • Zhong S.
        • Jiang Z.G.
        • et al.
        Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
        J Biol Chem. 2007; 282: 24270-24283
        • Hooper A.J.
        • Burnett J.R.
        Recent developments in the genetics of LDL deficiency.
        Curr Opin Lipidol. 2013; 24: 111-115
        • Sankatsing R.R.
        • Fouchier S.W.
        • de Haan S.
        • et al.
        Hepatic and cardiovascular consequences of familial hypobetalipoproteinemia.
        Arterioscler Thromb Vasc Biol. 2005; 25: 1979-1984
        • Tanoli T.
        • Yue P.
        • Yablonskiy D.
        • Schonfeld G.
        Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity.
        J Lipid Res. 2004; 45: 941-947
        • Welty F.K.
        • Lahoz C.
        • Tucker K.L.
        • Ordovas J.M.
        • Wilson P.W.
        • Schaefer E.J.
        Frequency of ApoB and ApoE gene mutations as causes of hypobetalipoproteinemia in the framingham offspring population.
        Arterioscler Thromb Vasc Biol. 1998; 18: 1745-1751
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Nauck M.
        • Warnick G.R.
        • Rifai N.
        Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.
        Clin Chem. 2002; 48: 236-254
        • Nordestgaard B.G.
        A test in context: lipid profile, fasting versus nonfasting.
        J Am Coll Cardiol. 2017; 70: 1637-1646
        • Martin S.S.
        • Giugliano R.P.
        • Murphy S.A.
        • et al.
        Comparison of low-density lipoprotein cholesterol assessment by martin/hopkins estimation, friedewald estimation, and preparative ultracentrifugation: insights from the FOURIER trial.
        JAMA Cardiol. 2018; 3: 749-753
        • Whelton S.P.
        • Meeusen J.W.
        • Donato L.J.
        • et al.
        Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol <70 mg/dL compared with a novel low-density lipoprotein estimation method.
        J Clin Lipidol. 2017; 11: 1065-1072
        • Ramasamy I.
        Update on the laboratory investigation of dyslipidemias.
        Clin Chim Acta. 2018; 479: 103-125
        • van Deventer H.E.
        • Miller W.G.
        • Myers G.L.
        • et al.
        Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.
        Clin Chem. 2011; 57: 490-501
        • Mora S.
        • Rifai N.
        • Buring J.E.
        • Ridker P.M.
        Comparison of LDL cholesterol concentrations by Friedewald calculation and direct measurement in relation to cardiovascular events in 27,331 women.
        Clin Chem. 2009; 55: 888-894
        • Saeedi R.
        • Li M.
        • Allard M.
        • Frohlich J.
        Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol.
        Clin Biochem. 2014; 47: 1098-1099
        • Olsson A.G.
        • Angelin B.
        • Assmann G.
        • et al.
        Can LDL cholesterol be too low? Possible risks of extremely low levels.
        J Intern Med. 2017; 281: 534-553
        • Packard C.J.
        LDL cholesterol: how low to go?.
        Trends Cardiovasc Med. 2017; 28: 348-354
        • Freedman D.S.
        • Srinivasan S.R.
        • Cresanta J.L.
        • Webber L.S.
        • Berenson G.S.
        Cardiovascular risk factors from birth to 7 years of age: the Bogalusa Heart Study. Serum lipids and lipoproteins.
        Pediatrics. 1987; 80: 789-796
        • Brown M.S.
        • Goldstein J.L.
        A receptor-mediated pathway for cholesterol homeostasis.
        Science. 1986; 232: 34-47
        • Orth M.
        • Bellosta S.
        Cholesterol: its regulation and role in central nervous system disorders.
        Cholesterol. 2012; 2012: 19
        • Zhang J.
        • Liu Q.
        Cholesterol metabolism and homeostasis in the brain.
        Protein Cell. 2015; 6: 254-264
        • Sezer K.
        • Emral R.
        • Corapcioglu D.
        • Gen R.
        • Akbay E.
        Effect of very low LDL-cholesterol on cortisol synthesis.
        J Endocrinol Invest. 2008; 31: 1075-1078
        • Cohen J.C.
        • Boerwinkle E.
        • Mosley Jr., T.H.
        • Hobbs H.H.
        Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.
        N Engl J Med. 2006; 354: 1264-1272
        • Kathiresan S.
        • Melander O.
        • Guiducci C.
        • et al.
        Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.
        Nat Genet. 2008; 40: 189-197
        • Cordain L.
        • Eaton S.B.
        • Miller J.B.
        • Mann N.
        • Hill K.
        The paradoxical nature of hunter-gatherer diets: meat-based, yet non-atherogenic.
        Eur J Clin Nutr. 2002; 56: S42-S52
        • O'Keefe Jr., J.H.
        • Cordain L.
        Cardiovascular disease resulting from a diet and lifestyle at odds with our Paleolithic genome: how to become a 21st-century hunter-gatherer.
        Mayo Clin Proc. 2004; 79: 101-108
        • Schonfeld G.
        • Patterson B.W.
        • Yablonskiy D.A.
        • et al.
        Fatty liver in familial hypobetalipoproteinemia: triglyceride assembly into VLDL particles is affected by the extent of hepatic steatosis.
        J Lipid Res. 2003; 44: 470-478
        • Schwartz G.G.
        • Steg P.G.
        • Szarek M.
        • et al.
        Alirocumab and cardiovascular outcomes after acute coronary syndrome.
        N Engl J Med. 2018; 379: 2097-2107
        • Ajufo E.
        • Rader D.J.
        Recent advances in the pharmacological management of hypercholesterolaemia.
        Lancet Diabetes Endocrinol. 2016; 4: 436-446
        • Hooper A.J.
        • Robertson K.
        • Barrett P.H.
        • Parhofer K.G.
        • van Bockxmeer F.M.
        • Burnett J.R.
        Postprandial lipoprotein metabolism in familial hypobetalipoproteinemia.
        J Clin Endocrinol Metab. 2007; 92: 1474-1478
        • Bacon B.R.
        • Farahvash M.J.
        • Janney C.G.
        • Neuschwander-Tetri B.A.
        Nonalcoholic steatohepatitis: an expanded clinical entity.
        Gastroenterology. 1994; 107: 1103-1109
        • Parhofer K.G.
        • Barrett P.H.
        • Aguilar-Salinas C.A.
        • Schonfeld G.
        Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes.
        J Lipid Res. 1996; 37: 844-852
        • Chen Z.
        • Fitzgerald R.L.
        • Li G.
        • Davidson N.O.
        • Schonfeld G.
        Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele.
        J Lipid Res. 2004; 45: 155-163
        • Amaro A.
        • Fabbrini E.
        • Kars M.
        • et al.
        Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
        Gastroenterology. 2010; 139: 149-153
        • Pelusi S.
        • Baselli G.
        • Pietrelli A.
        • et al.
        Rare pathogenic variants predispose to hepatocellular carcinoma in nonalcoholic fatty liver disease.
        Sci Rep. 2019; 9: 3682
        • Lee J.
        • Hegele R.A.
        Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management.
        J Inherit Metab Dis. 2014; 37: 333-339
        • Lonardo A.
        • Tarugi P.
        • Ballarini G.
        • Bagni A.
        Familial heterozygous hypobetalipoproteinemia, extrahepatic primary malignancy, and hepatocellular carcinoma.
        Dig Dis Sci. 1998; 43: 2489-2492
        • Powell E.E.
        • Cooksley W.G.
        • Hanson R.
        • Searle J.
        • Halliday J.W.
        • Powell L.W.
        The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years.
        Hepatology. 1990; 11: 74-80
        • Di Leo E.
        • Magnolo L.
        • Pinotti E.
        • et al.
        Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia.
        Mol Genet Metab. 2009; 96: 66-72
        • Zhu X.F.
        • Noto D.
        • Seip R.
        • Shaish A.
        • Schonfeld G.
        Organ loci of catabolism of short truncations of apoB.
        Arterioscler Thromb Vasc Biol. 1997; 17: 1032-1038
        • Tarugi P.
        • Averna M.
        Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum.
        Adv Clin Chem. 2011; 54: 81-107
        • Peloso G.M.
        • Nomura A.
        • Khera A.V.
        • et al.
        Rare protein-truncating variants in APOB, lower LDL-C, and protection against coronary heart disease.
        Circ Genom Precis Med. 2019; ([e-pub ahead of print])https://doi.org/10.1161/CIRCGEN.118.002376
        • Ballestri S.
        • Lonardo A.
        • Losi L.
        • Pellegrini E.
        • Bertolotti M.
        • Loria P.
        Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?.
        Intern Emerg Med. 2009; 4: 71-73